Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.


CSE:BUX - Post by User

Post by geodcanon Jul 10, 2024 6:28pm
157 Views
Post# 36127345

No bid on Stockhouse site

No bid on Stockhouse siteand yet I have been on the bid for about a year for an order that will cost me thousands if the artificial support by managment stops.<br /> <br /> July 5th Bux insidered for about $500 worth of shares and Huang for 100 less a day or two earlier.<br /> <br /> I thought they were building a company with an objective based on success with their business but now, it seems, it is looking more like a managment playground.
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities